Publications by authors named "Flordeluna Mesina"

Acute leukemia, a highly perilous cancer, is diagnosed using invasive procedures like bone marrow aspirate and biopsy (BMA/BMB). This study investigated the use of artificial intelligence (AI)-enhanced Fourier transform infrared (FT-IR) spectroscopy as a non-invasive, reagent-free diagnostic alternative with high sensitivity and specificity. The spectral peak patterns of peripheral blood smears (PBS) from clinically healthy individuals ( = 50) BMA/BMB-confirmed acute leukemia patients ( = 50) were examined in the 1800-850 cm range.

View Article and Find Full Text PDF
Article Synopsis
  • Myeloproliferative neoplasms (MPN) are types of blood disorders that lead to the overproduction of blood cells and can significantly impact patients' quality of life, especially among those who are Philadelphia-negative, such as those with Polycythemia Vera (PV), Essential Thrombocytosis (ET), or Myelofibrosis (MF).
  • This study focused on the experiences of Filipino patients with MPN, using interviews to delve into their symptoms and how they perceive living with the disease.
  • Key findings revealed that patients experience a wide range of complex symptoms, such as fatigue and bone pain, while also struggling with feelings of anxiety and uncertainty about their condition, ultimately highlighting their journey toward acceptance and hope
View Article and Find Full Text PDF

Background: Myeloproliferative neoplasms (MPN) are hematologic malignancies characterized by cellular proliferation of one or more hematopoietic cell lines. Management has been focused on blood count control but addressing relief from symptoms and providing a better quality of life (QOL) are equally important in the care of these patients. The MPN Symptom Assessment Form-Total Symptom Score (MPN-SAF TSS) is used to determine symptoms at baseline and during treatment.

View Article and Find Full Text PDF

Vaccination is the most important strategy in preventing COVID-19. Vaccine efficacy and safety have been established in clinical trials but real-world data are useful to determine occurrence of adverse events in a population with heterogeneous characteristics. Knowledge on the hematologic events associated with different COVID-19 vaccines would be beneficial for patients as well as hematologists who oversee the care of these patients.

View Article and Find Full Text PDF